273 related articles for article (PubMed ID: 10844628)
1. A role for leukotrienes in cyclosporine nephrotoxicity.
Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
[TBL] [Abstract][Full Text] [Related]
2. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity.
Atakan A; Arikan H; Macunluoglu B; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):279-84. PubMed ID: 18261606
[TBL] [Abstract][Full Text] [Related]
3. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity.
Padi SS; Chopra K
Pharmacol Res; 2002 May; 45(5):413-20. PubMed ID: 12123630
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
[TBL] [Abstract][Full Text] [Related]
5. An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.
Aleo MD; Doshna CM; Fritz CA
Toxicol Appl Pharmacol; 2008 Jul; 230(1):126-34. PubMed ID: 18407308
[TBL] [Abstract][Full Text] [Related]
6. Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury.
Spurney RF; Ibrahim S; Butterly D; Klotman PE; Sanfilippo F; Coffman TM
J Immunol; 1994 Jan; 152(2):867-76. PubMed ID: 8283057
[TBL] [Abstract][Full Text] [Related]
7. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.
Satyanarayana PS; Chopra K
Ren Fail; 2002 May; 24(3):259-74. PubMed ID: 12166693
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet activating factor in kidney transplant rejection in the rat.
Butterly DW; Spurney RF; Ruiz P; Pirotzky E; Braquet P; Coffman TM
Kidney Int; 1995 Aug; 48(2):337-43. PubMed ID: 7564100
[TBL] [Abstract][Full Text] [Related]
10. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats.
Mähler N; Freyer M; Kauschke R; Schlüter T; Steinbach AC; Oswald S; Miehe B; Krebs A; Rettig R; Grisk O
Pharmacogenet Genomics; 2012 Jun; 22(6):408-20. PubMed ID: 21869731
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
Sun QL; Li M; Rui HL; Chen YP
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):301-10. PubMed ID: 25500744
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.
Vieira JM; Noronha IL; Malheiros DM; Burdmann EA
Transplantation; 1999 Dec; 68(11):1746-53. PubMed ID: 10609952
[TBL] [Abstract][Full Text] [Related]
13. Is there a beneficial effect of the calcium channel blocker diltiazem on cyclosporine A nephrotoxicity in rats?
Kuhn UD; Lupp A; Kostka E; Kühl A; Balogh A; Stein G; Fleck C
Exp Toxicol Pathol; 1998 Sep; 50(4-6):484-90. PubMed ID: 9784027
[TBL] [Abstract][Full Text] [Related]
14. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
Macunluoglu B; Arikan H; Atakan A; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):273-8. PubMed ID: 18261605
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of tea polyphenols on renal cell apoptosis in rat test subjects suffering from cyclosporine-induced chronic nephrotoxicity.
Shi S; Zheng S; Zhu Y; Jia C; Xie H
Chin Med J (Engl); 2003 Sep; 116(9):1345-50. PubMed ID: 14527363
[TBL] [Abstract][Full Text] [Related]
16. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.
Young BA; Burdmann EA; Johnson RJ; Alpers CE; Giachelli CM; Eng E; Andoh T; Bennett WM; Couser WG
Kidney Int; 1995 Aug; 48(2):439-48. PubMed ID: 7564111
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity.
Pérez-Rojas J; Blanco JA; Cruz C; Trujillo J; Vaidya VS; Uribe N; Bonventre JV; Gamba G; Bobadilla NA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F131-9. PubMed ID: 16835406
[TBL] [Abstract][Full Text] [Related]
18. Previous exposure to cigarette smoke aggravates experimental cyclosporine-induced nephrotoxicity.
Alves SA; Carlos CP; Mendes GE; Oliveira SM; Luz MA; Souza RP; Matimoto RL; Coimbra TM; Burdmann EA
Am J Nephrol; 2012; 36(4):334-41. PubMed ID: 23018139
[TBL] [Abstract][Full Text] [Related]
19. Polymerized type I collagen reduces chronic cyclosporine nephrotoxicity.
Sánchez-Pozos K; Lee-Montiel F; Pérez-Villalva R; Uribe N; Gamba G; Bazan-Perkins B; Bobadilla NA
Nephrol Dial Transplant; 2010 Jul; 25(7):2150-8. PubMed ID: 20139407
[TBL] [Abstract][Full Text] [Related]
20. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats.
Hagar HH; El Etter E; Arafa M
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):189-96. PubMed ID: 16487261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
